Only seven people have opted out of a proposed $2.375-million settlement in a class-action lawsuit involving diluted chemotherapy treatment.

Wednesday was the deadline for more than 1,200 patients named in the class action to opt out of the proposed settlement.

Lawyer Harvey Strosberg of Stutts Strosberg LLP, the co-counsel in the lawsuit, says the majority of the patients are unopposed.

Each patient named in the lawsuit would receive about $1,500 under the proposed settlement.

Strosberg feels this is the best they can do and “if we go to trial, we will lose badly.”

Strossberg tells CTV News based on science and evidence, the case would have been very difficult to win in court.

“Reduction in chemotherapy seven to 10 per cent will not affect result,” says Strosberg. “That’s the evidence.”

Strosberg did say about 45 people have decided to file a notice of objection, including Louise Martens.

Martens is one of about 290 patients named in the lawsuit who are from Windsor-Essex.

“I hope with the strength in numbers and all the notices that have been filed the judge will say $1,500 is not sufficient,” says Martens.

The case goes back to 2012, when it was discovered that over 1,200 patients allegedly received diluted chemotherapy.

The proposed settlement will go before a judge for approval on Jan. 10.

The allegations made in the lawsuits have not been proven in court and the court has not taken any position as to the truth or merits of the claims or defences asserted by either side.